BATIBAY, S. Et Al. 2022. Immunogenicity and safety of the CoronaVac and BNT162b2 Covid-19 vaccine in patients with inflammatory rheumatic diseases and healthy adults: comparison of different vaccines. INFLAMMOPHARMACOLOGY , vol.30, no.6 , 2089-2096.

BATIBAY, S., Ulucakoy, R. K., GÜNENDİ, Z., FİDAN, I., BOZDAYI, G., & GÖĞÜŞ, F. N., (2022). Immunogenicity and safety of the CoronaVac and BNT162b2 Covid-19 vaccine in patients with inflammatory rheumatic diseases and healthy adults: comparison of different vaccines. INFLAMMOPHARMACOLOGY , vol.30, no.6, 2089-2096.

BATIBAY, SEVİLAY Et Al. "Immunogenicity and safety of the CoronaVac and BNT162b2 Covid-19 vaccine in patients with inflammatory rheumatic diseases and healthy adults: comparison of different vaccines," INFLAMMOPHARMACOLOGY , vol.30, no.6, 2089-2096, 2022

BATIBAY, SEVİLAY Et Al. "Immunogenicity and safety of the CoronaVac and BNT162b2 Covid-19 vaccine in patients with inflammatory rheumatic diseases and healthy adults: comparison of different vaccines." INFLAMMOPHARMACOLOGY , vol.30, no.6, pp.2089-2096, 2022

BATIBAY, S. Et Al. (2022) . "Immunogenicity and safety of the CoronaVac and BNT162b2 Covid-19 vaccine in patients with inflammatory rheumatic diseases and healthy adults: comparison of different vaccines." INFLAMMOPHARMACOLOGY , vol.30, no.6, pp.2089-2096.

@article{article, author={SEVİLAY BATIBAY Et Al. }, title={Immunogenicity and safety of the CoronaVac and BNT162b2 Covid-19 vaccine in patients with inflammatory rheumatic diseases and healthy adults: comparison of different vaccines}, journal={INFLAMMOPHARMACOLOGY}, year=2022, pages={2089-2096} }